After AI express, investors ask on the investor interaction platform: why doesn’t MP, a subsidiary, apply to FDA for certification? Is the product nonconforming or why?
Valiant Co.Ltd(002643) (002643. SZ) said on the investor interaction platform on February 12 that the covid-19 antigen rapid detection kit products of MP biomedicals, LLC, a subsidiary of the company, have not passed FDA certification at present. If they pass FDA certification later, The company will make disclosure on cninfo.com and other designated information disclosure media in strict accordance with relevant regulations and in combination with the actual situation.
